Ernexa Therapeutics (ERNA) Shares Outstanding (2010 - 2026)
Ernexa Therapeutics' Shares Outstanding was 1.18 million in Q2 2026, down 77.2% from 5.18 million a year earlier but up 49.4% from the prior quarter.
Ernexa Therapeutics (ERNA) Shares Outstanding (2010 - 2026) Analysis & Trends
For FY2025, Shares Outstanding at Ernexa Therapeutics came in at 6.31 million, up 593.2% from FY2024.
- Shares Outstanding has now increased for five consecutive years, with a five-year compound annual growth rate of 154.9% (FY2020 to FY2025).
- In earlier years, Shares Outstanding was 909,845 in FY2024 (+156.8%), 354,284 in FY2023 (+74.2%), 203,410 in FY2022 (+40.9%) and 144,341 in FY2021 (+146.2%).
- Quarterly Shares Outstanding has moved between 144,341 (Q4 2021) and 8.23 million (Q3 2025) over five years.
- Compared with a year earlier, Shares Outstanding was higher in three of the last six quarters, with growth averaging 246.9%.
- The best year-over-year quarter for Shares Outstanding over five years was Q1 2025 (growth of 886.3%); the worst was Q1 2026 (a decline of 77.7%).
- Per Business Quant data, ERNA's Shares Outstanding in the three quarters before Q2 2026 was 792,000 (Q1 2026), 6.31 million (Q4 2025) and 8.23 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Ernexa Therapeutics | 3.74 Mn | 3.74 Mn | - | 1.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 792,000.00 |
| Dec 31, 2025 | 6.31 Mn |
| Sep 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 5.18 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | 909,845.00 |
| Sep 30, 2024 | 360,685.00 |
| Jun 30, 2024 | 360,685.00 |
| Mar 31, 2024 | 360,685.00 |
| Dec 31, 2023 | 354,284.00 |
| Sep 30, 2023 | 360,685.00 |
| Jun 30, 2023 | 353,551.00 |
| Mar 31, 2023 | 341,817.00 |
| Dec 31, 2022 | 203,410.00 |
| Sep 30, 2022 | 196,076.00 |
| Jun 30, 2022 | 196,010.00 |
| Mar 31, 2022 | 178,742.00 |
| Dec 31, 2021 | 144,341.00 |
| Sep 30, 2021 | 168,475.00 |
Ernexa Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ERNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();